机器人辅助腹腔镜前列腺癌根治术中后路肌筋膜重建治疗临床局限性前列腺癌:一项Cochrane综述
本Cochrane综述纳入8项随机对照试验(6篇全文、2篇摘要),共1085例临床局限性前列腺癌患者,比较后路肌筋膜重建机器人辅助腹腔镜前列腺癌根治术(PR-RALP)与标准机器人辅助腹腔镜前列腺癌根治术(S-RALP)。PR-RALP可能在拔除导尿管1周时改善尿控(RR 1.25,95%CI 0.90-1.73;低确定性证据),但3个月时可能几乎无影响;严重不良事件可能几乎无差异(RR 0.75,95%CI 0.29-1.92;中等确定性证据)。
要点
- PR-RALP可能在拔除导尿管1周时改善尿控,但证据确定性低。
- PR-RALP对术后3个月尿控可能几乎无影响,证据确定性低。
- PR-RALP与S-RALP在严重不良事件上可能几乎无差异,证据确定性中等。
核心结论
- PR-RALP可能在拔除导尿管1周时改善早期尿控,但此后无改善。
- 不良事件发生率可能不受影响,切缘阳性率可能相似。
- 亚组分析中,联合前路重建与PR相比仅PR在所有结局上无差异。
研究设计与样本
- 系统检索无限制,纳入比较PR-RALP与S-RALP的随机对照试验。
- 共纳入8项独特随机对照试验的13条记录,其中6项为已发表研究,2项为摘要会议录。
- 共1085例随机患者,其中963例完成试验。
- 所有患者为cT1c或cT2或cT3a疾病。
- 证据质量按GRADE方法基于结局评估。
主要发现
- 拔除导尿管1周尿控:PR-RALP vs 无PR,RR 1.25,95%CI 0.90-1.73;I²=42%,5项研究,498例患者,低确定性证据。
- 术后3个月尿控:PR-RALP vs 无PR,RR 0.98,95%CI 0.84-1.14;I²=67%,6项研究,842例患者,低确定性证据。
- 严重不良事件:PR-RALP vs 无PR,RR 0.75,95%CI 0.29-1.92;I²=0%,6项研究,835例患者,中等确定性证据。
- 切缘阳性率可能相似(原文未报告具体数值)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the effects of posterior musculofascial reconstruction robot-assisted laparoscopic prostatectomy (PR-RALP) compared to no PR during standard RALP (S-RALP) for the treatment of clinically localised prostate cancer. PATIENTS AND METHODS: We performed a systematic search with no restrictions including randomised controlled trials (RCTs) comparing variations of PR-RALP vs S-RALP for clinically localised prostate cancer. The quality of evidence was assessed on outcome basis according to Grades of Recommendation, Assessment, Development and Evaluation (GRADE) approach. Our search identified 13 records of eight unique RCTs, of which six were published studies, and two were abstract proceedings. There were 1085 randomised patients, of whom 963 completed the trials. All patients had either cT1c or cT2 or cT3a disease. RESULTS: A PR-RALP may improve urinary continence 1 week after catheter removal compared to no PR (risk ratio [RR] 1.25, 95% confidence interval [CI] 0.90-1.73; I2 = 42%, five studies, 498 patients, low certainty of evidence [CoE]). A PR-RALP may have little to no effect on urinary continence 3 months after surgery compared to no PR (RR 0.98, 95% CI 0.84-1.14; I2 = 67%, six studies, 842 patients, low CoE). A PR-RALP probably results in little to no difference in serious adverse events compared to no PR (RR 0.75, 95% CI 0.29-1.92; I2 = 0%, six studies, 835 patients, moderate CoE). CONCLUSIONS: This review found evidence that PR-RALP may improve early continence 1 week after catheter removal but not thereafter. Meanwhile, adverse event rates are probably not impacted and positive surgical margin rates are likely similar. There was no difference in our subgroup analysis for all outcomes with anterior reconstruction technique when combined with PR vs only PR.
引用
- Rosenberg JE, Jung JH, Lee H, et al. Posterior musculofascial reconstruction in robot-assisted laparoscopic prostatectomy for the treatment of clinically localised prostate cancer: a Cochrane Review. BJU Int. 2021. PMID: 34825456. doi:10.1111/bju.15657
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。